… Combined treatment of chemotherapeutics and small interfering RNAs (siRNAs) using
folate ligands is a promising therapy strategy for breast carcinoma. One example was recently …

… This review summarizes evidence-based approaches to the systemic and local treatment
of the 3 major breast cancer subtypes: hormone receptor positive/ERBB2 negative (HR+/…

… Breast cancer … treatment approaches for patient groups. This article discusses the advantages
and disadvantages of sequential and combination therapies in metastatic breast cancer, …

… single-agent treatment groups. During combined treatment or treatment with buserelin alone,
… suppressed equally; in contrast, during treatment with tamoxifen alone, plasma estradiol …

… study, treatment failure occurred in 24 per cent of 179 control patients and in 5.3 per cent of
207 women given combination … The optimal treatment for primary breast cancer has been the …

… combination treatment especially in chemotherapy. Currently used combination treatments
in metastatic breast cancer … to the introduction of novel combination anticancer drug delivery …

… Effective therapy of breast cancer requires maximum … This review discusses therapeutic
options for breast cancer treatments … of combination therapy in the clinical management of breast …

… treatment groups, mice that received the combined treatment … mice that received the
combination treatment and those that … those that received the combination treatment was …

… effect of combined treatment with tamoxifen was additive (MCF-7 cells) or less than additive
(ZR-75-1 cells). Our data on the effect of combined treatment with tamoxifen and vitamin D3 …

… cell migration and invasion was also significantly inhibited by dasatinib alone treatment or
dasatinib-containing combination treatment in TNBC cell lines (89). Therefore, clinical studies …